🇺🇸 FDA
Patent

US 10836702

Compositions and methods comprising resveratrol

granted A61KA61K2800/10A61K31/618

Quick answer

US patent 10836702 (Compositions and methods comprising resveratrol) held by Biocogent, LLC expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Biocogent, LLC
Grant date
Tue Nov 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K2800/10, A61K31/618, A61K8/37